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1. Introduction 
Experiments of Reed [l] and Wieland [2] 
revealed that pyruvate dehydrogenase (PDH) activity 
may be regulated by reversible interconversion from 
the active (dephosphorylated) to the inactive (phos- 
phorylated) form of the enzyme. In the experiments 
performed in vivo it was found that PDH in various 
tissues including the brain occurs in the active as well 
as in the inactive state [2,3]. The ratio of the two 
forms depends on nutritional and hormonal condi- 
tions in kidney, heart and liver [3,4] but not in the 
brain [5] . 
From the studies of Wieland [6], Martin [7] and 
Waajtys [8] it results that PDH activity in isolated 
rat liver mitochondria depends on their energy state. 
Under conditions of controlled respiration the 
percentage of PDH in the active form varied directly 
with ADP content and inversely with ATP/ADP ratio. 
This mechanism has been shown recently to operate 
also in isolated brain mitochondria [9]. 
In the present study we investigate the possibility 
that PDH activity may be regulated in vivo by inter- 
conversion of the active to inactive form depending 
on the energy state of the brain. Experimental 
conditions have been sought which either increase 
(barbiturate anesthesia) or decrease (hypoxia, 
postdecapitative ischemia) the energy state of the 
brain. 
2. Materials and methods 
Experiments were carried on 200-250 g guinea 
North-Holland Publishing Company - Amsterdam 
pigs fed a standard diet. Five experimental models 
were used: 
(1) Pentobarbital anesthesia was applied by intro- 
ducing Nembutal i.p. in doses of 35 mg/kg body 
weight. Anesthetized animals were decapitated after 
30 min of sleep. 
(2) The animals were subjected to 3 min hypoxia 
in a chamber with continuous flow of 2-3% O2 in 
N2. 
(3) In the experiments on postdecapitative ischemia 
heads of animals were kept in a thermostat for 3 min 
at 37°C. 
(4) and (5) Hypoxia or ischemia as described in 
points (2) and (3) was preceded by 30 min of pento- 
barbital anesthesia. 
Immediately after decapitation heads of the 
animals were immersed in liquid nitrogen to prevent 
post-mortem changes in the active/inactive PDH 
forms. Frozen brain tissue (forebrain) was homo- 
genized with 5 vol. of a medium containing: 20 mM 
Tris-HCl pH 7, 1 mM dithiothreitol and 50% glycerol 
v/v at about -10°C [4]. 
Active PDH form was assayed after sonication of 
the homogenate for 3 X 10 set at - 10°C 20 kHz in 
MSE Ultrasonic Disintegrator (150 W), micro-probe, 
amplitude 14 pm. Total PDH activity was determined 
after enzymatic activation consisting in 5 min incuba- 
tion of the homogenate with PDH-phosphatase in the 
presence of 10 mM MgC12 at 25°C (fig.1). PDH-phos- 
phatase was purified from pig heart muscle up to step 
6 of the procedure described by Siess and Wieland 
UOI. 
PDH activity was determined radiochemically after 
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Land and Clark [ 111. The assay mixture contained: 
100 mM Tris-HCl, pH 8, 0.5 mM MgC12, 10 mM 
2-mercaptoethanol, 6.7 mM NAD, 2.7 mM thiamine 
pyrophosphate, 0.5 mM CoA, 1 mM L-malate, LDH 
50 U/ml, 8.3 mM pyruvate ([ l-‘4C]pyruvate, 0.1 
@i/ml) and about 1 mg of protein in a total vol of 
1.5 ml. The addition of L-malate was shown by Pate1 
and Tilghman [ 121 to inhibit carboxylation of 
pyruvate by pyruvate carboxylase. The reaction was 
run in the main chamber of the Warburg’s flask with 
a center well containing Hyamine with continuous 
shaking at 25°C. The reaction was started by adding 
the homogenate and stopped after 30 min by adding 
0.5 ml of 4 M HCl to the main chamber and the 
contents of the flask were shaken for a further 60 
min to facilitate complete absorption of the released 
14C02 by Hyamine. Hyam ine was transferred to the 
counting vials with 7 ml of Bray’s scintillator and 
counted for radioactivity in Isocap 300 (Nuclear 
Chicago liquid scintillation counter). All assays were 
run in duplicate in parallel with control determina- 
tions where homogenate or CoA were omitted. Protein 
was estimated by the method of Lowry et al. [ 131. 
Statistical significance was evaluated by Student’s 
t-test. 
3. Results 
Table 1 illustrates the contribution of the active 
form of PDH to the total enzyme activity in the 
forebrains of guinea pigs subjected to various experi- 
mental conditions. The total PDH activity remained 
unchanged in all the conditions examined. In the 
control conditions the active form of PDH made 62% 
of the total enzyme activity. The active form of the 
enzyme was observed to increase by about 40% in 
hypoxia and ischemia, showing a 40% drop in 
anesthesia. This means that in hypoxia or ischemia 
the active form of PDH makes as much as 90% and 
in anesthesia only 38% of the total enzyme activity. 
The conclusion that in anesthesia the equilibrium 
Table 1 
Active form and total activity of pyruvate dehydrogenase in guinea pig brain. 
Effect of hypoxia, &hernia and barbiturate anesthesia 
Conditions 
Pyruvate dehydrogenase activity, nmoles/mg of protein/h 
Active form % Total % Fraction of 
of control of control total activity 
Control 248 100 398 100 0.62 
f 35 (4) t 22 (4) 
Hypoxia 339 137 400 101 0.85 
* 18 (4) f 30 (4) 
Ischemia 359 145 384 96 0.93 
+ 36 (4) f 20 (4) 
Anesthesia 145 58 379 95. 0.38 
f 29 (3) * 17 (4) 
Anesthesia 233 94 358 90 0.65 
+ 
Hypoxia + 50 (4) * 9 (3) 
Anesthesia 368 148 363 91 1.01 
+ 
Ischemia f 86 (3) + 36 (3) 
Values represent means f SD for number of experiments given in brackets. 
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Fig.1. Effect of hypoxia, &hernia and barbiturate anesthesia on the activation of pyruvate dehydrogenase in guinea-pig brain 
homogenate. The homogenate corresponding to 10 mg of protein was incubated for 5 min at 25°C with 9-54 mU PDH 
phosphatase/mg of protein in the presence of 10 mM MgCl,. PDH phosphatase activity was 3 W/ml as assayed according to (lo]. 
Each point represents the mean for 3-4 experiments. a = NS, b = P < 0.05, ' = P < 0.01 with respect to maximum values in each 
group indicated by arrows. 
between the active and inactive form of PDH is 
shifted towards the latter phosphorylated one finds 
support in the results of experiments on the effect of 
the PDH phosphatase on the PDH activation (fig. 1). 
PDH obtained from the brains of anesthetized animals 
requires 2.5 times more PDH phosphatase for its full 
activation as compared to the enzyme derived from 
the control animals. In contrast, PDH from hypoxic 
or ischemic animals achieved near maximum activation 
with less PDH-phosphatase than PDH from control 
animals. 
When ischemia or hypoxia were applied to pre- 
viously anesthesized animals, these two models of 
oxygen deficiency appeared to affect differently the 
proportion of the active and inactive form of the 
enzyme. In animals in which anesthesia was followed 
by hypoxia, the active form of PDH remained on the 
control level, suggesting that the effects of anesthesia 
and hypoxia were additive. No such additive effect 
was observed when anesthesia was followed by 
ischemia. In these conditions all the PDH is in the 
active form. 
4. Discussion 
The existence of the active and inactive form of 
PDH in rat brain was demonstrated by Wieland et al. 
[2,.5] . They found that in brains from adult, normal 
fed rats the active form made up some 70% of the 
total PDH activity. In our experiments the percentage 
of PDH in the active form amounted to 62% in 
guinea pig brain. The present results indicate that 
the amount of the active form of PDH in the brain 
strongly depends upon its functional state. 
A number of studies have shown that barbiturate 
anesthesia nd hypoxia essentially differ in their 
effects on both the functional and energy state of the 
brain. Anesthesia and in particular barbiturate anes- 
thesia is considered as a high energy state of the 
brain, characterized by inhibition of the energy- 
consuming processes [141. This finds manifestation 
in slowing down of cellular syntheses, rise in the 
high energy compounds’ level (e.g. phosphocreatine), 
increase of the ATP/ADP ratio and decrease of the 
NADH/NAD or lactate/pyruvate ratios [ 15,161. In 
contrast to anesthesia, hypoxia and ischemia are 
accompanied by a decreased supply of the high energy 
compounds and well-known disturbances of the 
above mentioned metabolic indices [ 15- 191. 
Studies on isolated liver mitochondria [6,7,20] 
have demonstrated that operation of the PDH activity 
control mechanism consisting in the active-inactive 
form interconversion, mainly depends upon the level 
of ADP which protects PDH against the phosphoryl- 
ating and inactivating action of the PDH kinase, but 
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Table 2 
Comparison of various data concerning the level of several substrates in the brain under various conditions (% of control value) 
Hypoxia postdecap. Ischemia Anesthesia Anesthesia 
Substrates + ischemia 
100% N, 5% 0, 5% 0, 3 min Pheno- Pento- 3 min 
1.5 min 3 min 15 min barbital barbital 
ATP 55 96 18 11 106 53 
ADP 244 116 190 136 79 155 
ATP/ADP 23 83 10 8 135 34 
Pyruvate 460 167 30 695 
AcCoA 124 66 98 
Animal rat rat mouse 1 O-days-old 
mouse 
References [ 171 (181 [I91 [I61 
also upon the pyruvate level, which plays a protective 
role too. 
To analyze the possible correlation between the 
changes in the level of the active form of PDH and 
the known changes in the concentration of meta- 
bolites affecting interconversion, literature data 
concerning the ADP, pyruvate and AcCoA levels and 
the ATP/ADP ratio in the brains of animals subjected 
to similar experimental conditions were gathered and 
are presented in table 2. This presentation is limited 
to the data obtained on rats and mice, since those for 
guinea pigs are incomplete in the available literature. 
A strong correlation between those parameters 
may be concluded. The proportion of the active form 
of PDH was found to increase in the conditions 
known to lead to elevation of the ADP and pyruvate 
levels and decrease of the ATP/ADP ratio in the 
brain, the conditions including hypoxia, ischemia and 
ischemia after anesthesia. The lack of data on these 
compounds’ level in hypoxia after anesthesia excludes 
the possibility to discuss this model. 
A similar correlation, though in the opposite 
direction, characterizes the effect of barbiturate 
anesthesia. 
The above analysis of the present results and of the 
literature data allows to suggest he existence in brain 
of the interconversion mechanism of PDH activity 
regulation, with ADP and pyruvate serving as factors 
protecting the enzyme against inactivating action of 
PDH kinase; the same mechanism has been demon- 
strated in purified enzyme [.5,21] and in isolated liver 
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[6,7,20] and recently brain [9] mitochondria. 
The question arises as to the physiological signifi- 
cance of the observed changes in the active form of 
PDH and as to the relation of the amount of this form 
to the actual enzyme activity in vivo. 
There is an evident lack of correlation between 
the AcCoA level (table 2 after Schuberth [ 17,221, and 
PDH activity in a number of energy states of the brain 
(table 1). This is not a surprising finding, since the 
AcCoA level depends upon a number of enzyme 
activities and this is not an appropriate index of the 
rate of PDH-mediated pyruvate metabolism. 
In addition, regulation of PDH activity underlies 
some other mechanism, such as inhibition by the 
products: AcCoA [S] or NADH [23] , of which the 
level is related to the functional state of mitochondria 
and the rate of aerobic and anaerobic glycolysis. More 
detailed, dynamic studies, taking into account factors 
like concentration of Ca2+ and Mg*’ ions known to 
activate PDH phosphatase [I] and the cellular- and 
mitochondrial membrane permeability for pyruvate 
[24], are needed for further interpretations. 
References 
[II Reed, L. J., Linn, T. C., Hucho, F., Namihira, G., 
Barerra, C. R., Roche, T. E., Pelly, J. W. and Randall, 
D. D. (1972) in: Metabolic Interconversion of Enzymes 
(Wieland, 0. H., Helmreich, E. and Holzer, H., eds), 
Springer, Berlin, p. 281. 
Volume 63, number 1 FEBS LETTERS March 1976 
[2] Wieland, 0. H., Siess, E. A., v. Funcke, H. G., Patzelt, C., 
Schirmann, A., Loffler, G. and Weiss, L. (1972) in: 
Metabolic Interconversion of Enzymes (Wieland, 0. H., 
Helmreich, E. and Holzer, H., eds) Springer, Berlin, 
p. 293. 
I131 
I141 
[151 
[31 
I41 
151 
I61 
I71 
F31 
I91 
[lOI 
Wieland, 0. H., Siess, E. A., Schulze, Wethmar, F. H., 
Funcke, H. G. and Winton, B. (1972) Arch. Biochem. I161 
Biophys. 143, 593. 
Wieland, 0. H., Patzelt, C. and Lbffler, G. (1972) 
European _I. Biochem. 26,426. 
Siess, E. A., Wittmann, J. and Wieland, 0. H. (1971) 
Hoppe-Seyler’s 2. Physiol. Chem. 352,447. 
Wieland, 0. H. and Portenhauser, R. (1974) European 
[171 
iI81 
[191 
Lowry, 0. H., Rosebrough, N. J., Farr, A. L. and 
Randall, R. .I. (1951) J. Biol. Chem. 193, 265. 
McIlwain, H. (1966) Biochemistry and the CNS, p. 40, 
Churchchill, London. 
Goldberg, N. D., Passonneau, 3. V. and Lowry, 0. H. 
(1966) J. Biol. Chem. 241, 3997. 
Lowry, 0. H., Passonneau, J. V., Hasselberger, F. X. 
and Schulz, D. W. (1964) J. Biol. Chem. 239, 18. 
Schuberth, J., Sollenberg, J., Sundwall, A. and Sorbo, B. 
(1966) J. Neurochem. 13,819. 
Ridge, J. W. (1972) Biochem. J. 127, 351. 
Duffy, T. E., Nelson, S. R. and Lowry, 0. H. (1972) 
J. Neurochem. 19,959. 
J. Biochem. 45, 577. 
Martin, B. R., Denton, R. M., Pask, H. T. and Randle, 
P. J. (1972) Biochem. J. 129,763. 
Walajtys, E. I., Gottesman, D. P. and Williamson, J. R. 
(1974) J. Biol. Chem. 249, 1857. 
Jope, R. and Blass, J. P. (1975) Biochem. J. 150, 397. 
Siess, E. A. and Wieland, 0. H. (1972) European J. 
Biochem. 26,96. 
[20] Portenhauser, R. and Wieland, 0. H. (1972) European 
J. Biochem. 31, 308. 
WI 
VI 
1231 
Linn, T. C., Pettit, F. H., Hucho, F. and Reed, L. J. 
(1969) Proc. Natl. Acad. Sci. US 64, 227. 
Schuberth, J., SoIlenberg, J., Sundwall, A. and Sorbo, B. 
(1965) J. Neurochem. 12,451. 
Tsai, C. S., Burgett, M. W. and Reed, L. J. (1973) J. 
Biol. Chem. 248, 8348. 
Schuster, S. M. and Olson, M. S. (1974) J. Biol. Chem. 
249, 7159. 
[ll] Land, J. M. and Clark, J. B. (1973) Biochem. J. 134, 
539. 
1241 
[ 121 Patel, M. S. and Tilghman, S. M. (1973) Biochem. J. 
132. 185. 
153 
